Skip to content
OpenCapital
Get started

Danaher DHR Diagnostics — Operating Income (Loss)

Other segment segments

Biotechnology
$390M—
Life Sciences
$336M—

Similar metrics at other companies

Opko Health logo
OPKDiagnostics — Operating Income
$4.76M+126%
Revvity logo
RVTYDiagnostics — Segment operating income
$76.12M+2.8%
Labcorp Holdings logo
LHDiagnostics — Operating Income
$458.7M+7.3%
TEC
TECHDiagnostics And Spatial Biology — Operating Income
$10.32M+22.5%
Abbott logo
ABTDiagnostic Products — Operating Earnings
$499M+34.1%
Opko Health logo
OPKDiagnostics — Gross Profit
$16.09M-14.1%

Other financials

Income statement

See full
Revenue$6.3B+5.5%
Gross profit$3.6B+2.5%
Operating income$1.1B+48.3%
Net income$870.0M+56.8%
EPS (diluted)$1.23+59.7%

Balance sheet

See full
Cash & equivalents$4.3B+47.0%
Total debt$27.9B+50.1%
Total equity$52.6B+0.5%
Total assets$92.4B+13.2%

Cash flow

See full
Operating cash flow$1.5B+14.6%
CapEx$269.0M+8.5%
Free cash flow$1.3B+16.1%

Valuation

See full
Market cap$134.62B-7.4%
Enterprise value$158.13B-1.7%
P/E33.6×-9.0×
P/S5.4×-0.7×

Profitability

See full
Gross margin58.5%-1.1pp
Operating margin20.4%+2.0pp
Net margin15.9%+1.7pp
FCF margin21.8%+1.5pp

Returns & leverage

See full
Return on equity7.6%+1.0pp
Debt / equity0.5×+0.2×
Current ratio1.7×0.0×

Where this comes from

Reported directly by Danaher in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: Danaher’s 10-Q, filed July 21, 2026, on SEC EDGAR. View the filing →

Ask your AI about Danaher's diagnostics — operating income (loss).

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Danaher's diagnostics — operating income (loss)?
Danaher (DHR) reported diagnostics — operating income (loss) of $416M in Q2 2026.
How has Danaher's diagnostics — operating income (loss) changed year-over-year?
Danaher's diagnostics — operating income (loss) decreased by 24.9% year-over-year, from $554M to $416M.
What is the long-term trend for Danaher's diagnostics — operating income (loss)?
Over 2 years (2023 to 2025), Danaher's diagnostics — operating income (loss) has grown at a 4.9% compound annual growth rate (CAGR), from $2.41B to $2.65B.
What does diagnostics — operating income (loss) mean?
The profit earned from the diagnostics segment's core business operations after deducting operating expenses. It excludes interest, taxes, and non-operating items, providing a clear view of the segment's fundamental profitability. This is the primary metric for evaluating the operational efficiency of the diagnostics business.